FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014642132> ?p ?o ?g. }

• W2014642132 endingPage "335" @default.
• W2014642132 startingPage "328" @default.
• W2014642132 abstract "PURPOSE: Our preliminary report of imatinib mesylate (IM) in gastrointestinal stromal tumor (GIST) patients detailed a high response rate; however, the long-term result is still unknown. We conducted an analysis of Taiwan advanced inoperable/metastatic GIST patients treated on IM regarding survival, pattern of failure, potential prognostic factors, and mutational status. PATIENTS AND METHODS: From 2001 to 2010, patients with pathologically proven advanced inoperable/metastatic GIST receiving IM were enrolled onto this study. Data on KIT mutational status, measurable tumor size, and other potential prognostic factors were prospectively collected. Patients were followed up for a median of 33.6 months. RESULTS: There were 171 patients (106 men and 65 women) with response rate, and their clinical benefit for IM was 57.3% and 87.1%, respectively. Median progression-free survival (PFS) and overall survival (OS) for these 171 patients are 37.6 and 71.0 months, respectively. Of 171 patients, 120 (70.2%) remained on long-term IM use. Poor performance status, tumor larger than 11.5 cm, primary resistance, and the presence of an exon 9 mutation were independently associated with unfavorable PFS. Regarding OS, poor performance status, primary resistance, and tumor larger than 11.5 cm were three independently unfavorable predictors. CONCLUSIONS: The median PFS and OS of 171 GIST patients are 37.6 and 71.0 months, respectively. Poor performance status, tumor size larger than 11.5 cm, primary resistance, and an exon 9 mutation were independently associated with unfavorable PFS. Regarding OS, poor performance status, primary resistance, and tumor size larger than 11.5 cm were three independent unfavorable predictors." @default.
• W2014642132 created "2016-06-24" @default.
• W2014642132 creator A5001467169 @default.
• W2014642132 creator A5008104910 @default.
• W2014642132 creator A5021557615 @default.
• W2014642132 creator A5024370855 @default.
• W2014642132 creator A5037884937 @default.
• W2014642132 creator A5042413756 @default.
• W2014642132 creator A5043854641 @default.
• W2014642132 creator A5053209984 @default.
• W2014642132 creator A5082950787 @default.
• W2014642132 date "2011-12-01" @default.
• W2014642132 modified "2023-09-23" @default.
• W2014642132 title "Imatinib Mesylate for Patients with Recurrent or Metastatic Gastrointestinal Stromal Tumors Expressing KIT: A Decade Experience from Taiwan" @default.
• W2014642132 cites W1967773734 @default.
• W2014642132 cites W2015015957 @default.
• W2014642132 cites W2016086822 @default.
• W2014642132 cites W2019607817 @default.
• W2014642132 cites W2024676016 @default.
• W2014642132 cites W2055436404 @default.
• W2014642132 cites W2067333514 @default.
• W2014642132 cites W2079420659 @default.
• W2014642132 cites W2079978727 @default.
• W2014642132 cites W2107464631 @default.
• W2014642132 cites W2115504770 @default.
• W2014642132 cites W2119505091 @default.
• W2014642132 cites W2122333904 @default.
• W2014642132 cites W2134094496 @default.
• W2014642132 cites W2140626630 @default.
• W2014642132 cites W2143609320 @default.
• W2014642132 cites W2150501295 @default.
• W2014642132 cites W2171620774 @default.
• W2014642132 cites W2324850882 @default.
• W2014642132 cites W2328017321 @default.
• W2014642132 cites W4238208852 @default.
• W2014642132 doi "https://doi.org/10.1593/tlo.11253" @default.
• W2014642132 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3243655" @default.
• W2014642132 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22190996" @default.
• W2014642132 hasPublicationYear "2011" @default.
• W2014642132 type Work @default.
• W2014642132 sameAs 2014642132 @default.
• W2014642132 citedByCount "24" @default.
• W2014642132 countsByYear W20146421322012 @default.
• W2014642132 countsByYear W20146421322013 @default.
• W2014642132 countsByYear W20146421322014 @default.
• W2014642132 countsByYear W20146421322015 @default.
• W2014642132 countsByYear W20146421322017 @default.
• W2014642132 countsByYear W20146421322018 @default.
• W2014642132 countsByYear W20146421322019 @default.
• W2014642132 countsByYear W20146421322020 @default.
• W2014642132 countsByYear W20146421322021 @default.
• W2014642132 countsByYear W20146421322022 @default.
• W2014642132 crossrefType "journal-article" @default.
• W2014642132 hasAuthorship W2014642132A5001467169 @default.
• W2014642132 hasAuthorship W2014642132A5008104910 @default.
• W2014642132 hasAuthorship W2014642132A5021557615 @default.
• W2014642132 hasAuthorship W2014642132A5024370855 @default.
• W2014642132 hasAuthorship W2014642132A5037884937 @default.
• W2014642132 hasAuthorship W2014642132A5042413756 @default.
• W2014642132 hasAuthorship W2014642132A5043854641 @default.
• W2014642132 hasAuthorship W2014642132A5053209984 @default.
• W2014642132 hasAuthorship W2014642132A5082950787 @default.
• W2014642132 hasBestOaLocation W20146421321 @default.
• W2014642132 hasConcept C121608353 @default.
• W2014642132 hasConcept C126322002 @default.
• W2014642132 hasConcept C143998085 @default.
• W2014642132 hasConcept C16930146 @default.
• W2014642132 hasConcept C2775922572 @default.
• W2014642132 hasConcept C2776907518 @default.
• W2014642132 hasConcept C2777007597 @default.
• W2014642132 hasConcept C2777583451 @default.
• W2014642132 hasConcept C2778729363 @default.
• W2014642132 hasConcept C2779013556 @default.
• W2014642132 hasConcept C2780283643 @default.
• W2014642132 hasConcept C2780739268 @default.
• W2014642132 hasConcept C3019892230 @default.
• W2014642132 hasConcept C3019894029 @default.
• W2014642132 hasConcept C71924100 @default.
• W2014642132 hasConcept C90924648 @default.
• W2014642132 hasConceptScore W2014642132C121608353 @default.
• W2014642132 hasConceptScore W2014642132C126322002 @default.
• W2014642132 hasConceptScore W2014642132C143998085 @default.
• W2014642132 hasConceptScore W2014642132C16930146 @default.
• W2014642132 hasConceptScore W2014642132C2775922572 @default.
• W2014642132 hasConceptScore W2014642132C2776907518 @default.
• W2014642132 hasConceptScore W2014642132C2777007597 @default.
• W2014642132 hasConceptScore W2014642132C2777583451 @default.
• W2014642132 hasConceptScore W2014642132C2778729363 @default.
• W2014642132 hasConceptScore W2014642132C2779013556 @default.
• W2014642132 hasConceptScore W2014642132C2780283643 @default.
• W2014642132 hasConceptScore W2014642132C2780739268 @default.
• W2014642132 hasConceptScore W2014642132C3019892230 @default.
• W2014642132 hasConceptScore W2014642132C3019894029 @default.
• W2014642132 hasConceptScore W2014642132C71924100 @default.
• W2014642132 hasConceptScore W2014642132C90924648 @default.
• W2014642132 hasIssue "6" @default.
• W2014642132 hasLocation W20146421321 @default.
• W2014642132 hasLocation W20146421322 @default.

• next